Fund moves

Thermo Fisher Scientific (TMO): Omers Administration Corp reduced its stake -57K shares

Omers Administration Corp reduced its stake in Thermo Fisher Scientific, per its Q4 2025 13F.

423K
Shares reported · -57K vs prior quarter
1.8%
Disclosed portfolio weight
$245M
Reported value
Holdings as of
Dec 31, 2025
Filed
Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024Congress · 1 personMembers of Congress: 2 purchases
  2. Apr 28, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  3. Jul 25, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  4. Jan 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Each of Michel Lagarde and Frederick M. Lowery have notified Thermo Fisher Scientific Inc. (the “Company”) of their decisions to leave the Company to pursue other opportunities.”
  5. Jan 27, 2026Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 173 employees
  6. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  7. Feb 9, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  8. Feb 9, 2026InsiderOfficer sold ~$216K of TMO shares in the open market

What came next

  1. Mar 3, 2026Insider · 1 personInsiders: 12 sales (~$2.5M)
  2. Mar 4, 2026Insider · 1 personInsiders: 8 sales (~$2.6M)
  3. Mar 5, 2026Insider · 1 personInsiders: 13 sales (~$2.1M)
  4. Mar 11, 2026InsiderOfficer sold ~$803K of TMO shares in the open market
  5. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  6. Apr 23, 2026Company filing · Form 8-K · ResultsReported its results
  7. Apr 27, 2026InsiderOfficer sold ~$185K of TMO shares in the open market
  8. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  9. May 7, 2026CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
  10. Jun 4, 2026Federal contract · $1.6M obligatedDepartment of Defense awarded Thermo Fisher Scientific: $1.57M obligated to date
  11. Jun 9, 2026Federal contract · $1.5M obligatedDepartment of Agriculture awarded Thermo Fisher Scientific: $1.5M obligated to date
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

How this filing works

Explore the data

Common questions

What does this filing report about Thermo Fisher Scientific (TMO) stock?

Omers Administration Corp reduced its stake in Thermo Fisher Scientific, per its Q4 2025 13F. Now 423K shares, $245M reported value, 1.8% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Thermo Fisher Scientific recently?

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.

Does this mean TMO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data